Joel A Sincavage

Array ( [id] => 3949421 [patent_doc_number] => 05977308 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Platelet-activating factor acetylhydrolase' [patent_app_type] => 1 [patent_app_number] => 8/910041 [patent_app_country] => US [patent_app_date] => 1997-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 42674 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977308.pdf [firstpage_image] =>[orig_patent_app_number] => 910041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4093563 [patent_doc_number] => 06096542 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Cancer control' [patent_app_type] => 1 [patent_app_number] => 8/875944 [patent_app_country] => US [patent_app_date] => 1997-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 12772 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096542.pdf [firstpage_image] =>[orig_patent_app_number] => 875944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998991 [patent_doc_number] => 05986060 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Macrophage Migration Inhibitory Factor-3' [patent_app_type] => 1 [patent_app_number] => 8/903224 [patent_app_country] => US [patent_app_date] => 1997-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10558 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/986/05986060.pdf [firstpage_image] =>[orig_patent_app_number] => 903224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4367927 [patent_doc_number] => 06274562 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/880313 [patent_app_country] => US [patent_app_date] => 1997-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 12336 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274562.pdf [firstpage_image] =>[orig_patent_app_number] => 880313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3955780 [patent_doc_number] => 05935937 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Compositions and methods for inducing apoptosis' [patent_app_type] => 1 [patent_app_number] => 8/877831 [patent_app_country] => US [patent_app_date] => 1997-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 11 [patent_no_of_words] => 6386 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935937.pdf [firstpage_image] =>[orig_patent_app_number] => 877831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1331775 [patent_doc_number] => 06596537 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Human interleukin-6 receptor expression inhibitor' [patent_app_type] => B1 [patent_app_number] => 08/849949 [patent_app_country] => US [patent_app_date] => 1997-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4834 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596537.pdf [firstpage_image] =>[orig_patent_app_number] => 08849949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4152345 [patent_doc_number] => 06107094 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Oligoribonucleotides and ribonucleases for cleaving RNA' [patent_app_type] => 1 [patent_app_number] => 8/870608 [patent_app_country] => US [patent_app_date] => 1997-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 33129 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107094.pdf [firstpage_image] =>[orig_patent_app_number] => 870608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3932289 [patent_doc_number] => 05939317 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'Use of a Sec-dependent secretion system for secreting proteins that are usually secreted by a Sec-independent secretion system, bacteria containing it and their use' [patent_app_type] => 1 [patent_app_number] => 8/849373 [patent_app_country] => US [patent_app_date] => 1997-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2467 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939317.pdf [firstpage_image] =>[orig_patent_app_number] => 849373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4096754 [patent_doc_number] => 06048702 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Murine and human box-dependent myc-interacting protein (Bin1) and uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/870126 [patent_app_country] => US [patent_app_date] => 1997-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 7 [patent_no_of_words] => 31121 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048702.pdf [firstpage_image] =>[orig_patent_app_number] => 870126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4216197 [patent_doc_number] => 06110898 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'DNA vaccines for eliciting a mucosal immune response' [patent_app_type] => 1 [patent_app_number] => 8/862632 [patent_app_country] => US [patent_app_date] => 1997-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10540 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110898.pdf [firstpage_image] =>[orig_patent_app_number] => 862632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4204161 [patent_doc_number] => 06077705 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Ribozyme-mediated gene replacement' [patent_app_type] => 1 [patent_app_number] => 8/856331 [patent_app_country] => US [patent_app_date] => 1997-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 21 [patent_no_of_words] => 11000 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077705.pdf [firstpage_image] =>[orig_patent_app_number] => 856331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3995230 [patent_doc_number] => 05922566 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Tumor-associated antigen' [patent_app_type] => 1 [patent_app_number] => 8/855261 [patent_app_country] => US [patent_app_date] => 1997-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 18307 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922566.pdf [firstpage_image] =>[orig_patent_app_number] => 855261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4345893 [patent_doc_number] => 06214545 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Polymorphism analysis by nucleic acid structure probing' [patent_app_type] => 1 [patent_app_number] => 8/851588 [patent_app_country] => US [patent_app_date] => 1997-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 34 [patent_no_of_words] => 21142 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214545.pdf [firstpage_image] =>[orig_patent_app_number] => 851588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478383 [patent_doc_number] => 06344543 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-05 [patent_title] => 'Human transcription factor IIA' [patent_app_type] => B1 [patent_app_number] => 08/845011 [patent_app_country] => US [patent_app_date] => 1997-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 10008 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/344/06344543.pdf [firstpage_image] =>[orig_patent_app_number] => 08845011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4190120 [patent_doc_number] => 06153595 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Composition and method for treatment of CMV infections' [patent_app_type] => 1 [patent_app_number] => 8/838715 [patent_app_country] => US [patent_app_date] => 1997-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18230 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153595.pdf [firstpage_image] =>[orig_patent_app_number] => 838715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3923060 [patent_doc_number] => 05914269 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-22 [patent_title] => 'Oligonucleotide inhibition of epidermal growth factor receptor expression' [patent_app_type] => 1 [patent_app_number] => 8/832658 [patent_app_country] => US [patent_app_date] => 1997-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8119 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/914/05914269.pdf [firstpage_image] =>[orig_patent_app_number] => 832658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4063294 [patent_doc_number] => 06008050 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Human neurotensin receptor type 2 and splice variants thereof' [patent_app_type] => 1 [patent_app_number] => 8/832399 [patent_app_country] => US [patent_app_date] => 1997-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11179 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/008/06008050.pdf [firstpage_image] =>[orig_patent_app_number] => 832399 [rel_patent_id] =>[rel_patent_doc_number] =>)